Target intelligence / Profile preview

Voltage-gated sodium channel (site of action for local anesthetics) (VGSC (if referencing the channel class); specific subtypes (e.g., Nav1.7) may be used in primary literature, but not specified here due to lack of explicit information in the search results.)

Target
VGSC (if referencing the channel class); specific subtypes (e.g., Nav1.7) may be used in primary literature, but not specified here due to lack of explicit information in the search results.
Molecular classification
Ion channel, Voltage-gated ion channel
01

Overview

Local anesthetics produce analgesia by reversibly inhibiting voltage-gated sodium channels in neuronal membranes, thereby blocking the initiation and propagation of action potentials in peripheral nerves[1][2][4][5]. This mechanism prevents the transmission of pain and other sensory modalities from local tissue to the central nervous system, resulting in localized loss of pain sensation. Different classes of local anesthetics (amides and esters) act primarily at this molecular site, and their tissue effects can be modulated by formulations (e.g., liposomal bupivacaine) or adjuncts (e.g., vasoconstrictors) to prolong analgesia or reduce systemic toxicity[1][2][3][5].

Other names
Sodium channelVoltage-gated Na+ channelNav channelLocal anesthetic receptor (site)
02

Mechanism of action

Reversible blockade of voltage-gated sodium channels in neuronal membranes, inhibiting action potential propagation and thus preventing pain transmission[1][2][4][5]

03

Biological functions

Action potential propagationPain signal transmission (nociception)
04

Disease associations

InflammationPain (acute and chronic)Arrhythmia (for cardiac sodium channels)Other
05

Safety considerations

Neurotoxicity (at excessive concentrations or inadvertent intrathecal administration)Cardiotoxicity (especially with bupivacaine)Allergic reactions (rare, more common with ester-type agents)Differential nerve block (motor function impairment if concentrations are high)Systemic toxicity (CNS effects, seizures, respiratory depression)
06

Interacting drugs

Lidocaine

7 more in the full profile.

Beyond the preview

Go deeper on Voltage-gated sodium channel (site of action for local anesthetics) (VGSC (if referencing the channel class); specific subtypes (e.g., Nav1.7) may be used in primary literature, but not specified here due to lack of explicit information in the search results.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated sodium channel (site of action for local anesthetics) (VGSC (if referencing the channel class); specific subtypes (e.g., Nav1.7) may be used in primary literature, but not specified here due to lack of explicit information in the search results.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call